Joseph Donnelly
Foot & Ankle Surgery · Voorhees, NJNPI 1336190453
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (30.4%), other and consulting fees — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by Convatec Inc. at 26.8% of the total. Reporting peaked in 2019 at $8,484 and has fallen 96.2% since, to $322 in 2025. Among foot & ankle surgery clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 148 payments — averaging $116.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Convatec Inc.$5K
- Medical Device Business Services, Inc.$4K
- Treace Medical Concepts, Inc.$2K
- Arthrex$1K
- Arthrosurface Incorporated$1K
- Stryker$981
- plus $4K from 28 others
What the payments were for
- Consulting fees$3,60021%
- Travel & lodging$2,38314%
- Food & beverage$5,22630%
- Education$1,4038%
- Other$4,60027%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Convatec Inc. | 3 | $4,620 |
| Medical Device Business Services, Inc. | 4 | $3,645 |
| Treace Medical Concepts, Inc. | 11 | $1,540 |
| Arthrex | 1 | $1,403 |
| Arthrosurface Incorporated | 6 | $1,174 |
| Stryker(2 entities) | 16 | $981 |
| Smith+Nephew | 50 | $957 |
| Liberty Surgical Inc. | 7 | $926 |
| Paragon 28, Inc. | 4 | $242 |
| Cook Biotech Incorporated | 2 | $219 |
| Eclipse Technology Solutions Inc. | 2 | $192 |
| Zimmer Biomet | 3 | $174 |
| Johnson & Johnson | 2 | $149 |
| Biopro, Inc. | 1 | $119 |
| Organogenesis Inc. | 4 | $102 |
| Kerecis Limited | 3 | $100 |
| DJO, LLC | 2 | $84 |
| Reprise Biomedical, Inc. | 4 | $70 |
| Amgen | 4 | $63 |
| KCI USA, Inc. | 2 | $61 |
| Paratek Pharmaceuticals, Inc. | 4 | $56 |
| Medartis Inc. | 1 | $44 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $40 |
| Integra Lifesciences Corporation | 1 | $37 |
| Crossroads Extremity Systems, LLC | 1 | $35 |
| Anika Therapeutics, Inc. | 1 | $33 |
| Acera Surgical, Inc. | 1 | $25 |
| Avanos Medical | 1 | $25 |
| Mimedx Group, Inc. | 1 | $23 |
| Tactile Systems Technology Inc | 1 | $18 |
| EBI, LLC | 1 | $17 |
| GRT US Holding, Inc. | 1 | $14 |
| Pacira Pharmaceuticals Incorporated | 1 | $14 |
| Hikma Pharmaceuticals USA | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- InnovaMatrix AC$4,600
- Lapiplasty System$1,402
- HemiCAP MTP Resurfacing$998
- Grafix$299
- Cook Medical SIS$187
- INFINITY$157
- BIOskin$144
- ASNIS$138
- VARIAX$138
- SONICPIN$129
- EXTERNAL FIXATION$123
- Nextremity ArcusTM$106
How this compares
$17,211 in reported general payments places this provider in the 90th percentile of 542 foot & ankle surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 26 | $11,052 |
| JubliaEfinaconazole | 12 | $10,218 |
| Mupirocin | 45 | $597 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 26 | $285 |
| Ammonium Lactate | 12 | $136 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $957 | $11,05226 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 542 foot & ankle surgery providers in New Jersey.
Other foot & ankle surgery in Voorhees
- John CozzarelliBelleville$932K
- Matthew RegulskiToms River$843K
- Michael SubikLyndhurst$529K
- Krupa PatelMorris Plains$281K
- Johanna GodoyWayne$254K
- Andrew BriefRidgewood$253K
- Mark SolomonCedar Knolls$232K
- Evan AdlerOld Bridge$195K
- Shane HollawellManasquan$169K
- Jacob ReinkrautRidgewood$80K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.